Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,116,788
-$135,062 QoQ
Shares Held
27,145
-45.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Derivatives in ACLX
reported options exposure · as of Mar 31, 2025CallValue
$1,029,920
CallShares
15,700
PutValue
$806,880
PutShares
12,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. ACLX ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in ACLX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,116,788 | 27,145 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,251,850 | 49,875 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $1,056,497 | 16,044 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $806,880 | 12,300 | Put | Defined | 2025-08-27 | |
| 2025-03-31 | $1,029,920 | 15,700 | Call | Defined | 2025-08-27 | |
| 2024-12-31 | $408,757 | 5,330 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $835,100 | 10,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $873,602 | 15,829 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,416,315 | 121,011 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $305,250 | 5,500 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $7,168,158 | 129,156 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $1,242,507 | 39,295 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $515,790 | 16,741 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $782,864 | 25,270 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $420,600 | 30,000 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||